SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-15-000039
Filing Date
2015-01-09
Accepted
2015-01-09 12:29:14
Documents
5
Period of Report
2015-01-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_010815.htm 8-K 32266
2 UNDERWRITING AGREEMENT ex1-1.htm EX-1.1 187630
3 OPINION LETTER ex5-1.htm EX-5.1 11260
4 PRESS RELEASE ex99-1.htm EX-99.1 11992
5 PRESS RELEASE ex99-2.htm EX-99.2 10416
  Complete submission text file 0001387131-15-000039.txt   254841
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 15518290
SIC: 2834 Pharmaceutical Preparations